Gufic BioSciences Ltd share price logo

Gufic Bio Share Price

NSE: GUFICBIO

BSE: 509079

Small Cap

Healthcare Sector

₹328.15

+2.75

(+0.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Gufic Bio Stock Performance

as on November 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹322.05
    ₹338.35
    downward going graph

    1.86%

    Downside

    3.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹298.8
    ₹504.25
    downward going graph

    8.94%

    Downside

    53.66%

    Upside

    downward going graph

Gufic Bio share price movements today

Previous Close
₹325.40
Open
₹325.40
Volume
41.21K
Upper Circuit
₹390.45
Lower Circuit
₹260.35
Day's Low - High
₹322.05 - ₹338.35
52 Week Low - High
₹298.8 - ₹504.25

Gufic Bio Historical Returns

1 Month Return
-9.23 %
3 Month Return
-14.48 %
1 Year Return
-30.09 %
3 Year Return
+ 41.76 %
5 Year Return
+ 203.83 %

Gufic Bio Fundamentals

as on November 3, 2025 at 4:01 pm IST

Market Cap

₹3,263.19 Cr

Return on Equity (ROE)

12.33

PE Ratio (TTM)

52.74

Return on capital employed (ROCE)

12.88

Industry PE ratio

41.96

Beta (LTM)

0.94

P/B Ratio

5.61

Dividend Yield

0.03

PEG Ratio

-20.85

Quarterly Earnings Growth YOY

-37.34

EPS (TTM)

6.95

Sector

Pharmaceuticals

Book Value

59.93

Technical Analysis

Bearish

View Technical Analysis

Gufic Bio Stock Valuation

as on November 3, 2025 at 4:01 pm IST

Gufic Bio in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

March 28, 2024

Industry (41.96x)

October 31, 2025

Today (52.74x)

October 31, 2025

Highest (65.57x)

July 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 52.74x

Gufic BioSciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gufic Bio with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Gufic BioSciences Ltd image
Gufic BioSciences Ltd
NA3,263.1940.77%0.6969819
Mono Pharmacare Ltd image
Mono Pharmacare Ltd
NA35.34-6.86%0.823168
Kerala Ayurveda Ltd image
Kerala Ayurveda Ltd
NA513.82159.58%0.95-14125
Alpa Laboratories Ltd image
Alpa Laboratories Ltd
NA192.6729.43%0.5019112
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,363.91-1.51%0.7428311
See all

Gufic Bio Stock’s Investor Sentiment and Interest

Search interest for Gufic BioSciences Ltd Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Gufic BioSciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
195.02
214.87
201.78
194.99
202.81
204.18
207.79
205.02
223.72
Other Income
0.54
0.33
0.42
0.88
1.25
0.11
1.86
0.39
0.93
Total Income
195.56
215.21
202.2
195.87
204.07
204.29
209.66
205.41
224.65
Expenses
159.2
175.5
165.32
160.77
167.03
165.56
173.87
178.65
190.42
Operating Profit
35.82
39.37
36.46
34.22
35.78
38.62
33.92
26.37
33.3
Operating Profit Margin %
18.37%
18.32%
18.07%
17.55%
17.64%
18.91%
16.32%
12.86%
14.88%
Profit Before Interest, Tax and Depreciation
36.36
39.7
36.88
35.11
37.03
38.73
35.79
26.77
34.23
Interest
4.07
4.46
3.18
3.65
4.62
5.18
4.91
8.4
9.23
Depreciation
4.24
4.3
4.14
4.34
4.31
4.3
4.62
7.84
7.72
Profit Before Tax
28.05
30.94
29.56
27.12
28.1
29.25
26.26
10.53
17.28
Tax Paid
7.43
7.73
7.3
7.07
7.25
7.49
6.96
2.8
4.2
Profit After Tax
20.62
23.21
22.26
20.05
20.86
21.77
19.31
7.72
13.07
Total Net profit including share of profit / Loss from associate company
20.62
23.21
22.26
20.05
20.86
21.77
19.31
7.72
13.07
EPS
2.13
2.39
2.23
2
2.08
2.17
1.93
0.77
1.3
Actual EPS
2.13
2.39
2.23
2
2.08
2.17
1.93
0.77
1.3
Adjusted EPS
2.13
2.39
2.23
2
2.08
2.17
1.93
0.77
1.3
Diluted EPS
-
2.39
2.23
2
2.08
2.17
1.93
0.77
1.3

Gufic BioSciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2024
Mar 2025
Sales
806.67
819.81
Other Income
2.18
3.63
Total Income
808.84
823.43
Expenses
660.79
685.11
Operating Profit
145.88
134.7
Operating Profit Margin %
18.08%
16.43%
Profit Before Interest, Tax and Depreciation
148.05
138.32
Interest
15.36
23.11
Depreciation
17.02
21.06
Profit Before Tax
115.67
94.15
Tax Paid
29.54
24.49
Profit After Tax
86.14
69.65
Total Net profit including share of profit / Loss from associate company
86.14
69.65
EPS
8.74
6.95
Actual EPS
8.74
6.95
Adjusted EPS
8.74
6.95
Diluted EPS
8.74
6.95

Gufic BioSciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2024
Mar 2025
Net Cash from Operating Activities
-7.46
122.57
Cash Flow from Investing Activities
-102.38
-70.78
Cash Flow from Financing Activities
82.37
-37.21
Net Cash Flow
-27.47
14.59

Gufic Bio Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
75%
75%
75%
75%
72.51%
72.51%
72.51%
72.51%
72.51%
72.51%
72.51%
72.51%
72.5%
DII
1.16%
1.16%
1.16%
1.5%
1.58%
1.6%
2.2%
2.39%
2.51%
2.98%
3.39%
3.38%
3.65%
FII
0%
0%
0%
0%
0.72%
0%
0.12%
0.23%
0.24%
0.3%
0.31%
0.32%
0.34%
Public
23.69%
23.12%
23.14%
22.64%
25.19%
25.29%
25.17%
24.88%
24.74%
24.2%
23.79%
23.8%
23.51%
Total Outstanding Shares
9,69,44,506
9,69,44,506
9,69,44,506
9,69,44,506
10,02,77,506
10,02,77,506
10,02,77,506
10,02,77,506
10,02,77,506
10,02,77,506
10,02,77,506
10,02,77,506
10,02,82,506
Total Shareholders
40,562
38,902
38,624
36,557
36,524
34,424
34,695
32,250
32,825
33,299
31,844
31,876
31,420

Mutual Funds that own Gufic Bio Stock

Check out the Mutual Funds with significant holdings in Gufic Bio.

Gufic Bio Corporate Actions

View detailed summary of the earnings and dividend history of Gufic Bio.

  • Gufic BioSciences Ltd Earnings Results

    Gufic BioSciences Ltd’s net profit fell -37.34% since last year same period to ₹13.07Cr in the Q1 2025-2026. On a quarterly growth basis, Gufic BioSciences Ltd has generated 69.3% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Gufic BioSciences Ltd Dividends May,2025

    In the quarter ending March 2025, Gufic BioSciences Ltd has declared dividend of ₹0.10 per share on 30 May 2025 - translating a dividend yield of 0.03%.

    Read More about Dividends

Indices Featuring Gufic Bio Stock

Check stock indices that include Gufic Bio.

BSE Healthcare

₹45,036.92

1.14 (▲507.15%)

BSE Small-Cap

₹54,257.98

0.71 (▲381.84%)

Insights on Gufic BioSciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.32% to 0.34% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.38% to 3.48% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 14.2% return, outperforming this stock by 44.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 110.7% return, outperforming this stock by 68.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 23.80% to 23.51% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GUFICBIO stock has moved down by -3.0%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.51% to 72.50% in Sep 2025 quarter

About Gufic BioSciences Ltd

Gufic Biosciences (GBL) was established as a result of a reverse merger of itself and Central Finance at Rs 4042 per share, allowing for the company to be listed on the Bombay Stock Exchange. The Choksi and Gandhi family, the promoters of GBL, have a long-standing background in the pharmaceutical industry, having formed the joint venture company, Lyka Labs, in 1960. Gufic Biosciences, known as Gujarat Fine Chemicals, first operated in the bulk drug space, before moving into the formulation market. GBL currently offers ethical, herbal, consumer, and bulk drugs, both domestically and internationally, and have a history of creating leading brands. In 2000, GBL issued bonus equity shares at 5:2, and more recently the company has divested some of its assets in the ethical pharma business, with plans to reinvest in R&D activities, and to further invigorate the potential of the herbal and consumer product segments. With traditional knowledge in India, Gufic will be operating from a position of strength around those specific areas.

Revenue: ₹223.72Cr as on June 2025 (Q1 FY26)
Net Profit: ₹13.07Cr as on June 2025 (Q1 FY26)
Listing date: 19 Oct, 2004
Chairperson Name: Jayesh P Choksi
OrganisationGufic BioSciences Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOJayesh P Choksi
E-voting on sharesClick here to vote

FAQs

What is Gufic Bio share price today?

Gufic Bio share price today stands at ₹328.15 as on at the close of the market. Gufic Bio share today touched a day high of ₹338.35 and a low of ₹322.05.

What is the 52 week high and 52 week low range for Gufic Bio share?

Gufic Bio touched a 52 week high of ₹504.25 and a 52 week low of ₹298.8. Gufic Bio share price today i.e. is closed at ₹328.15, which is -34.92% down from its 52 week high and 9.82% up from its 52 week low.

What is Gufic Bio's market capitalisation today?

Gufic Bio market capitalisation is ₹3,263.19 Cr as on .

How to buy Gufic Bio shares?

To buy Gufic Bio shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GUFICBIO or Gufic BioSciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Gufic Bio shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Gufic Bio trading volume today?

Gufic Bio trading volume is 41.21K as on . This means that 41.21K shares of Gufic Bio were bought and sold on the stock market during today's trading session.